Updated August 6, 2026
The average analyst price target for Stem is $10.33 on a 12-month horizon. With the stock trading at $5.77, that leaves upside of +79.0%.
We define the fair-value range as ±10% of the price target, because price targets are estimates, not exact values. For Stem the range runs from $9.30 to $11.36 — which means the stock is considered undervalued.
Our overall score for Stem is 61/100 (value 98, quality 82, momentum 2). The price target shows where the analysts expect the price to go — our score shows how the company is doing right now. The strongest setup is when both point in the same direction.
The average analyst price target for Stem is $10.33 on a 12-month horizon. The current price is $5.77, which leaves upside of +79.0%. On that basis the stock is considered undervalued.
The fair-value range (±10% of the price target) for Stem runs from $9.30 to $11.36. The price currently sits below the range – the stock is considered undervalued.
A price target is the analysts' estimate of where the stock could be in 12 months – not a promise. Analysts often adjust their targets only after the price has already moved, so big turning points are sometimes missed. Use the price target as a reference point together with the technical signal as well as the key figures – never as a guarantee.
The price target is the average of the analysts' 12-month price targets (Wall Street consensus), refreshed daily from our data sources – together with the price, the signal, plus the key figures.
The price target is the average of the analysts' 12-month price targets (Wall Street consensus), updated daily. Analysis framework by Troels Højbjerg, the creator of WallStreetBuys. WallStreetBuys does not offer investment advice – trading stocks carries a risk of losses.